GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Dividend-Payout-to-FFO

Tevogen Bio Holdings (FRA:G28) Dividend-Payout-to-FFO


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Tevogen Bio Holdings Business Description

Traded in Other Exchanges
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.